Skip to main content

Table 1 Pharmacological parameters of cyclic analogues of glucagon

From: The Role of Salt Bridge Formation in Glucagon: An Experimental and Theoretical Study of Glucagon Analogs and Peptide Fragments of Glucagon

 

Receptor Binding Activity

Adenylyl Cyclase

Glucagon and Analogues

Relative Affinitya, (%)

Fold Decrease

Relative Potencyb, (%)

Maximum Activityc (%)

pA2d Value

1A Glucagon

100

 

100

100

1B Glucagon amide

100

 

15

100

1C DesHis1glucagon

8

12.5

0.1

36

1D DesHis1glucagon amide

63

1.6

0.16

44

2 Cyclic[Glu2Lys5]-amide

0.41

244

0.58

100

 

3 Cyclic[Glu9Lys12]-amide

4.8

21

0.126

18

4 DesHis1cyclic[Glu9 Lys12]-amide

12.6

8

<0.00013

6.9

5 DesHis1Glu9cyclic[Glu20 Lys24]-amide

19.1

5.3

<0.003

6.8

  1. aThe ratio of unlabeled glucagon concentration required to displace 50% of receptor-bound [125I]-glucagon, IC50, to the concentration required for analogues of glucagon × 100.
  2. bThe ratio of glucagon concentration at 50% stimulation (EC50) of natural glucagon to that of glucagon analogue × 100.
  3. cThe ratio of maximum response of glucagon analogue to that of natural glucagon × 100.
  4. dpA2 value is the negative logarithm of the concentration of inhibitor that reduces the response to 1 unit of agonist to the response obtained from 0.5 unit of agonist.